Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.

Miroslav TurjapMarta PelcováJana GregorováPavel ŠmakHiroko MartinJan ŠtinglOndřej PešJan Juřica

Published in: Therapeutic drug monitoring (2024)

Sufficient evidence supports the therapeutic drug monitoring of pazopanib in adult patients to improve its efficacy and/or safety in the approved indications.

Keyphrases

renal cell carcinoma